Bill Griffin is Executive Vice President and Senior Managing Director of Fidelity National Financial. In this role, Bill helps lead Fidelity’s efforts to deliver its end-to-end solutions to the country’s largest financial institutions. Because of his leadership in and knowledge of the mortgage industry, Bill has served on the Board of Directors for the Mortgage Bankers Association since 2013.
Dr. Steve Stice is Co-Founder and Chief Scientific Officer of Aruna Biomedical, Inc, where he directs the company’s clinical and research operations. He is also University of Georgia, DW Brooks Distinguished Professor and Director of the Regenerative Bioscience Center, and holds a Georgia Research Alliance Eminent Scholar endowed chair.
Dr. Mark Sirgo is Chief Executive Officer of Aruna Bio. Dr. Sirgo brings over 35 years of pharmaceutical experience to Aruna Bio from drug development through global product commercialization. Most recently, Dr. Sirgo served as President and CEO of BioDelivery Sciences International (BDSI:Nasdaq), a specialty pharmaceutical company focused in CNS/pain. While leading BDSI, Dr. Sirgo was successful in raising nearly $600 million in capital through partnerships and financings to support the development, FDA approval and commercial launch of three products utilizing the company’s proprietary drug delivery technology.
Darren W. DeVore serves Managing Partner of Broad Pine Investments, the holding company for various private equity and venture capital activities. Broad Pine maintains investments in several businesses including The Carroll Organization, one of the country's leading privately held real estate companies focused on multifamily investment, management, and development. Other investments include Terra Partners, a private equity company focused on acquisition and management of logistics businesses within the FedEx system and Battle Investment Group, a private equity firm operating in the North American defense/security, government and industrial markets.
Mr. Ingalls brings over 40 years of financial leadership to Aruna Bio and during his career he has served in the capacity of chief financial officer for nearly two decades. Most recently, Mr. Ingalls served as Chief Financial Officer of SeraCare Life Sciences a private life sciences tools company focused on diagnostic products.
Skip has spent more than 35 years advising companies on business strategy, technology commercialization, R&D planning, and mergers and acquisitions in the biotech, pharmaceutical and medical products industry.
Rusty Lindner is Executive Chairman and CEO of The Forge Company, a private Washington, DC- based transportation holding company whose principal operating units are Colonial Parking, Inc. (DC) and The Washington Boat Lines. Mr. Lindner also serves as the CEO of PortfolioFirst Parking Solutions, an international parking asset management firm founded in 2001, as well as of Bear Saint Properties, a Washington, DC commercial real estate investment firm.
John F. Mangan, Jr. has been active in the U.S. money management and securities industry for over 35 years. He is currently the CEO of JFM Capital, a Charlotte NC based private investment firm with interests in the capital markets and in several private businesses. From 1999 to 2007, Mangan was founder/CEO/CIO of Mangan McColl Partners, LLC, a US alternative asset manager that managed over $1.4B.
Barry L. Storey is the Principal of BLS Holdings Group, LLC, an Augusta, Georgia-based company with the primary focus of managing a portfolio of retail real estate properties and various alternative assets. Prior to January 2015, he was the Co-Founding Partner of Hull Storey Gibson Companies, LLC, a retail acquisition and development real estate company founded in 1992 that owned and operated over 13 million square feet of retail strip centers and enclosed mall properties in the Southeast.
A long-time entrepreneur and financier, Mr. Townley has overseen financial strategy and operations of fast-growing enterprises for over 30 years. Mr. Townley is Co-founder, Executive Vice President and Chief Strategy Officer of Zaxby’s Franchising, one of the fastest-growing restaurant franchise systems in the United States.
John Richard is Co-Founder and Chief Business Officer for Mereo BioPharma plc, a publicly-traded biopharmaceutical company founded in 2015. Mr. Richard previously served in various roles, including Director and Operating Partner, with Phase4 Partners, a life science investment firm.